{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:04:32Z","timestamp":1773288272850,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17am0301021h0003"],"award-info":[{"award-number":["17am0301021h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17ek0109154h0003"],"award-info":[{"award-number":["17ek0109154h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17ek0109239h0001"],"award-info":[{"award-number":["17ek0109239h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K07544"],"award-info":[{"award-number":["18K07544"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.omtn.2019.01.008","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T06:04:24Z","timestamp":1548569064000},"page":"520-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Scavenger Receptor Class A1 Mediates Uptake of Morpholino Antisense Oligonucleotide into Dystrophic Skeletal Muscle"],"prefix":"10.1016","volume":"14","author":[{"given":"Shouta","family":"Miyatake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Mizobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria K.","family":"Tsoumpra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji Rowel Q.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fazel","family":"Shabanpoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshifumi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin\u2019ichi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitsugu","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2019.01.008_bib1","first-page":"2471","article-title":"Recent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trials","volume":"8","author":"Shimizu-Motohashi","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.omtn.2019.01.008_bib2","doi-asserted-by":"crossref","first-page":"13763","DOI":"10.1073\/pnas.1204638109","article-title":"Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense delivery","volume":"109","author":"Aoki","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2019.01.008_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrd3625","article-title":"RNA therapeutics: beyond RNA interference and antisense oligonucleotides","volume":"11","author":"Kole","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2019.01.008_bib4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2174\/1389201043376706","article-title":"Neutrally charged phosphorodiamidate morpholino antisense oligomers: uptake, efficacy and pharmacokinetics","volume":"5","author":"Arora","year":"2004","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.omtn.2019.01.008_bib5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1073\/pnas.0406700102","article-title":"Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles","volume":"102","author":"Lu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2019.01.008_bib6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.21627","article-title":"Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs","volume":"65","author":"Yokota","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2019.01.008_bib7","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.4155\/fmc.15.116","article-title":"Antisense oligonucleotide drugs for Duchenne muscular dystrophy: how far have we come and what does the future hold?","volume":"7","author":"Guncay","year":"2015","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.omtn.2019.01.008_bib8","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1517\/14712598.2014.896335","article-title":"New developments in exon skipping and splice modulation therapies for neuromuscular diseases","volume":"14","author":"Touznik","year":"2014","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.omtn.2019.01.008_bib9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nrneurol.2016.180","article-title":"Eteplirsen therapy for Duchenne muscular dystrophy: skipping to the front of the line","volume":"12","author":"Dowling","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.omtn.2019.01.008_bib10","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.toxrep.2015.05.008","article-title":"The use of urinary and kidney SILAM proteomics to monitor kidney response to high dose morpholino oligonucleotides in the mdx mouse","volume":"2","author":"Zhang","year":"2015","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.omtn.2019.01.008_bib11","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1021\/bc070060v","article-title":"Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate","volume":"18","author":"Amantana","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omtn.2019.01.008_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1089\/nat.2014.0528","article-title":"Development and application of an ultrasensitive hybridization-based ELISA method for the determination of peptide-conjugated phosphorodiamidate morpholino oligonucleotides","volume":"25","author":"Burki","year":"2015","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2019.01.008_bib13","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.2147\/IJN.S36111","article-title":"The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles","volume":"7","author":"Fr\u00f6hlich","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.omtn.2019.01.008_bib14","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","article-title":"Dystrophin protects the sarcolemma from stresses developed during muscle contraction","volume":"90","author":"Petrof","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2019.01.008_bib15","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/mus.880171206","article-title":"Time course of changes in plasma membrane permeability in the dystrophin-deficient mdx mouse","volume":"17","author":"McArdle","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtn.2019.01.008_bib16","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1093\/hmg\/ddt341","article-title":"Highly efficient in\u00a0vivo delivery of PMO into regenerating myotubes and rescue in laminin-\u03b12 chain-null congenital muscular dystrophy mice","volume":"22","author":"Aoki","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2019.01.008_bib17","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41467-017-00924-7","article-title":"Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle","volume":"8","author":"Novak","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2019.01.008_bib18","doi-asserted-by":"crossref","first-page":"10981","DOI":"10.1038\/ncomms10981","article-title":"Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice","volume":"7","author":"Han","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2019.01.008_bib19","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1021\/acs.nanolett.5b00490","article-title":"Self-assembly into nanoparticles is essential for receptor mediated uptake of therapeutic antisense oligonucleotides","volume":"15","author":"Ezzat","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.omtn.2019.01.008_bib20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nri3515","article-title":"Scavenger receptors in homeostasis and immunity","volume":"13","author":"Canton","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtn.2019.01.008_bib21","doi-asserted-by":"crossref","first-page":"R193","DOI":"10.1016\/S1074-5521(98)90156-9","article-title":"Scavenger receptors: diverse activities and promiscuous binding of polyanionic ligands","volume":"5","author":"Platt","year":"1998","journal-title":"Chem. Biol."},{"key":"10.1016\/j.omtn.2019.01.008_bib22","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/4033","article-title":"Expression of full-length utrophin prevents muscular dystrophy in mdx mice","volume":"4","author":"Tinsley","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2019.01.008_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ymeth.2007.06.004","article-title":"Macrophage scavenger receptors and host-derived ligands","volume":"43","author":"Pl\u00fcddemann","year":"2007","journal-title":"Methods"},{"key":"10.1016\/j.omtn.2019.01.008_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ejpb.2010.11.010","article-title":"Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages","volume":"77","author":"Arnida","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.omtn.2019.01.008_bib25","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1113\/expphysiol.2014.082404","article-title":"Regulation of exercise-induced lipid metabolism in skeletal muscle","volume":"99","author":"Jordy","year":"2014","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.omtn.2019.01.008_bib26","doi-asserted-by":"crossref","first-page":"e1000829","DOI":"10.1371\/journal.ppat.1000829","article-title":"An accessory to the \u2018Trinity\u2019: SR-As are essential pathogen sensors of extracellular dsRNA, mediating entry and leading to subsequent type I IFN responses","volume":"6","author":"DeWitte-Orr","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2019.01.008_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-065X.2008.00728.x","article-title":"Conserved domains of the class A scavenger receptors: evolution and function","volume":"227","author":"Bowdish","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.omtn.2019.01.008_bib28","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1093\/nar\/gkt1220","article-title":"Cellular trafficking determines the exon skipping activity of Pip6a-PMO in mdx skeletal and cardiac muscle cells","volume":"42","author":"Lehto","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.01.008_bib29","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1038\/mtna.2012.30","article-title":"Pip6-PMO, a new generation of peptide-oligonucleotide conjugates with improved cardiac exon skipping activity for DMD treatment","volume":"1","author":"Betts","year":"2012","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2019.01.008_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-4939-7374-3_9","article-title":"Exon skipping therapy using phosphorodiamidate morpholino oligomers in the mdx52 mouse model of Duchenne muscular dystrophy","volume":"1687","author":"Miyatake","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2019.01.008_bib31","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/mt.2010.72","article-title":"Preclinical PK and PD studies on 2\u2032-O-methyl-phosphorothioate RNA antisense oligonucleotides in the mdx mouse model","volume":"18","author":"Heemskerk","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.01.008_bib32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajpath.2011.03.050","article-title":"Restoring dystrophin expression in duchenne muscular dystrophy muscle progress in exon skipping and stop codon read through","volume":"179","author":"Hoffman","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtn.2019.01.008_bib33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1286-4579(00)01362-9","article-title":"The function of scavenger receptors expressed by macrophages and their role in the regulation of inflammation","volume":"3","author":"Peiser","year":"2001","journal-title":"Microbes Infect."},{"key":"10.1016\/j.omtn.2019.01.008_bib34","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1212\/WNL.25.12.1111","article-title":"Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber","volume":"25","author":"Mokri","year":"1975","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2019.01.008_bib35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3940(02)00267-7","article-title":"Changes in the distribution and density of caveolin 3 molecules at the plasma membrane of mdx mouse skeletal muscles: a fracture-label electron microscopic study","volume":"325","author":"Shibuya","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.omtn.2019.01.008_bib36","doi-asserted-by":"crossref","first-page":"30315","DOI":"10.1074\/jbc.274.42.30315","volume":"274","author":"Galbiati","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2019.01.008_bib37","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.bbadis.2010.12.005","article-title":"Point mutated caveolin-3 form (P104L) impairs myoblast differentiation via Akt and p38 signalling reduction, leading to an immature cell signature","volume":"1812","author":"Stoppani","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtn.2019.01.008_bib38","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/mt.2010.186","article-title":"In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse","volume":"18","author":"Aoki","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.01.008_bib39","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1189\/jlb.2A0414-214R","article-title":"Lipid rafts couple class A scavenger receptors to phospholipase A2 activation during macrophage adhesion","volume":"96","author":"Vadali","year":"2014","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.omtn.2019.01.008_bib40","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1194\/jlr.M200231-JLR200","article-title":"Class A scavenger receptors mediate cell adhesion via activation of G(i\/o) and formation of focal adhesion complexes","volume":"43","author":"Post","year":"2002","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.omtn.2019.01.008_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-4939-3810-0_5","article-title":"Inducing and evaluating skeletal muscle injury by notexin and barium chloride","volume":"1460","author":"Tierney","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2019.01.008_bib42","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1089\/hum.2006.061","article-title":"Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle","volume":"18","author":"Arechavala-Gomeza","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2019.01.008_bib43","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.35.5.758","article-title":"Activity, creatine kinase, and myoglobin in Duchenne muscular dystrophy: a clue to etiology?","volume":"35","author":"Florence","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2019.01.008_bib44","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1006\/bbrc.1999.1055","article-title":"Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy","volume":"261","author":"Repetto","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtn.2019.01.008_bib45","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1078\/0344-0338-00058","article-title":"Muscle plasma membrane changes in dystrophin gene exon 52 knockout mouse","volume":"197","author":"Shibuya","year":"2001","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.omtn.2019.01.008_bib46","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1194\/jlr.M300424-JLR200","article-title":"Sarcolemmal FAT\/CD36 in human skeletal muscle colocalizes with caveolin-3 and is more abundant in type 1 than in type 2 fibers","volume":"45","author":"Vistisen","year":"2004","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.omtn.2019.01.008_bib47","first-page":"1479","article-title":"Internalization and fate of silica nanoparticles in C2C12 skeletal muscle cells:\u00a0evidence of a beneficial effect on myoblast fusion","volume":"10","author":"Poussard","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.omtn.2019.01.008_bib48","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.2147\/DDDT.S110163","article-title":"Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors","volume":"10","author":"Miyatake","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.omtn.2019.01.008_bib49","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0022-3565(24)35317-0","article-title":"Phosphorothioate oligodeoxynucleotides distribute similarly in class A scavenger receptor knockout and wild-type mice","volume":"292","author":"Butler","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.omtn.2019.01.008_bib50","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1093\/nar\/gkw112","article-title":"Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liver","volume":"44","author":"Miller","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.01.008_bib51","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/14712598.2013.774366","article-title":"Influence of diverse chemical modifications on the ADME characteristics and toxicology of antisense oligonucleotides","volume":"13","author":"Dirin","year":"2013","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.omtn.2019.01.008_bib52","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1600-0854.2009.00878.x","article-title":"Defining macropinocytosis","volume":"10","author":"Kerr","year":"2009","journal-title":"Traffic"},{"key":"10.1016\/j.omtn.2019.01.008_bib53","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijpharm.2006.08.025","article-title":"Fetuin mediates hepatic uptake of negatively charged nanoparticles via scavenger receptor","volume":"329","author":"Nagayama","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.omtn.2019.01.008_bib54","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1096\/fj.11-191536","article-title":"Scavenger receptor-mediated uptake of cell-penetrating peptide nanocomplexes with oligonucleotides","volume":"26","author":"Ezzat","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.omtn.2019.01.008_bib55","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-1-61779-767-5_23","article-title":"Overview of alternative oligonucleotide chemistries for exon skipping","volume":"867","author":"Saleh","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2019.01.008_bib56","doi-asserted-by":"crossref","first-page":"e0120058","DOI":"10.1371\/journal.pone.0120058","article-title":"In silico screening based on predictive algorithms as a design tool for exon skipping oligonucleotides in Duchenne muscular dystrophy","volume":"10","author":"Echigoya","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2019.01.008_bib57","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1006\/bbrc.1997.7328","article-title":"Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy","volume":"238","author":"Araki","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtn.2019.01.008_bib58","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/386292a0","article-title":"A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection","volume":"386","author":"Suzuki","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2019.01.008_bib59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ydbio.2009.10.005","article-title":"Muscle satellite cells are a functionally heterogeneous population in both somite-derived and branchiomeric muscles","volume":"337","author":"Ono","year":"2010","journal-title":"Dev. Biol."},{"key":"10.1016\/j.omtn.2019.01.008_bib60","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1073\/pnas.1613203114","article-title":"Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy","volume":"114","author":"Echigoya","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253119300125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253119300125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:21:01Z","timestamp":1762600861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253119300125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":60,"alternative-id":["S2162253119300125"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2019.01.008","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735095532.793560209","asserted-by":"object"}]},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scavenger Receptor Class A1 Mediates Uptake of Morpholino Antisense Oligonucleotide into Dystrophic Skeletal Muscle","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2019.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors.","name":"copyright","label":"Copyright"}]}}